ΕΠΙΚΟΙΝΩΝΙΑ

Ρωτήστε τη γιατρό

Alopecia Areata

What is Alopecia Areata?

Alopecia Areata is an autoimmune disorder characterized by patchy hair loss on otherwise healthy skin, resulting from an immune-mediated attack on the hair follicles. In mild cases, hair loss is limited to specific areas, whereas more severe forms can progress to total or universal alopecia and are often linked to genetic predisposition.

The condition is reversible, as hair follicles typically remain viable and capable of regenerating hair. Alopecia Areata can occur at any age, with highly variable progression between individuals, and it affects both sexes equally.

  • Personalized Treatment Strategies
  • Advanced Therapeutic Approaches
  • Customized Therapeutic Protocols
  • Efficacy Without Unnecessary Discomfort

Symptoms of Alopecia Areata

The clinical presentation of Alopecia Areata varies significantly among individuals. The pattern of hair loss and regrowth, as well as the severity and duration of the disease, is unpredictable. However, common symptoms include:

  • The appearance of small, round or oval bald patches on the scalp or other areas such as the eyebrows and eyelashes.
  • Simultaneous hair loss and regrowth in different regions of the body.
  • Rapid hair loss within a short period, often more pronounced on one side of the scalp.
  • Presence of “exclamation mark” hairs—short, broken hairs that are thinner at the base and thicker at the end.

Even when the disease is active, hair regrowth remains possible, including in cases where more than 50% of the scalp is affected or following a prolonged disease course.

Types of Alopecia Areata

  • Patchy Alopecia Areata: The most common form, presenting as one or more well-demarcated bald patches on the scalp or body.
  • Alopecia Totalis: Characterized by complete loss of scalp hair.
  • Alopecia Universalis: Involves total loss of hair from the scalp, face, and body.

Causes of Alopecia Areata

Alopecia Areata is a multifactorial disease influenced by genetic, immunological, psychological, endocrine, and environmental factors.

Management Strategies for Alopecia Areata

The treatment of Alopecia Areata requires a multimodal approach tailored to disease severity and individual patient response. Therapeutic options include both topical and systemic modalities, adjusted to the extent of the condition.

Topical Therapies

  • Corticosteroids: Most effective in mild cases, particularly via intralesional triamcinolone injections. Their efficacy is limited in more extensive disease such as totalis or universalis.
  • Topical Immunotherapy (Diphencyprone – DPCP): Among the most effective treatments for extensive or treatment-resistant cases. Requires weekly application and may cause mild erythema or pruritus.
  • Irritant Agents:
    • Anthralin: Suitable for patients with dark hair, applied in high concentrations with frequent use.
    • Retinoic Acid: More appropriate for lighter hair and also requires regular application.
  • Minoxidil: Applied topically, minoxidil enhances hair regrowth, particularly in combination with other therapies. It is considered safe, though individual responses vary.

Systemic Therapies

  • Oral Corticosteroids: Can be effective but require high doses, posing a risk of toxicity and frequent relapses, making them less desirable for severe cases.
  • Cyclosporine: High-dose regimens may yield good results, although efficacy diminishes upon cessation, limiting long-term acceptance.
  • Calcineurin Inhibitors (e.g., Tacrolimus): Show promising results in studies and are being investigated as potential additions to current treatment protocols.
  • Phototherapy (PUVA): Indicated in extensive cases, offering broader immunomodulatory effects.
  • Zinc Sulfate: Used systemically to support immune regulation in Alopecia Areata.
  • Systemic Corticosteroids: While effective in some cases (particularly in pulse dosing), frequent relapses and potential toxicity limit their long-term use in severe forms.

Novel Therapies

  • JAK Inhibitors: In Alopecia Areata, the immune system mistakenly targets hair follicles. JAK inhibitors (e.g., baricitinib, ritlecitinib) suppress this autoimmune reaction, enabling the regrowth of scalp, eyebrow, and eyelash hair. These agents represent a major breakthrough in the treatment of resistant forms of the disease.

Alternative Approaches

  • Wigs and Eyebrow Tattoos: These cosmetic options offer aesthetic enhancement, contributing significantly to patients’ psychological well-being and self-esteem.
Καλέστε μας